Pediatric patients who use melatonin may experience a reduction in the percentage of rapid eye movement (REM) sleep compared to those who do not, according to a cross-sectional study published in JAMA Network Open. Researchers analyzing data from 3,392 children at Nationwide Children’s Hospital found that melatonin users had a median REM sleep percentage of 16.7%, compared to 19.0% among matched nonusers.
Impact of Melatonin on Pediatric Sleep Architecture
While melatonin is the most frequently used sleep supplement among children—with usage rates reaching up to 19% in recent 30-day periods—clinical data on its effect on objective sleep patterns has been limited. Most existing research relies on parent-reported outcomes or actigraphy rather than polysomnography (PSG), which is considered the gold standard for measuring sleep architecture.
The study, which utilized a database of 3,984 PSG evaluations, sought to address this gap by examining how the supplement influences specific sleep stages. Beyond the noted decrease in REM sleep, the researchers observed no significant differences in 14 other measured PSG outcomes. These included total sleep time, sleep efficiency, sleep onset latency, and various respiratory indices, such as the oxygen desaturation index and periodic limb movements.
Did you know?
REM sleep and slow-wave sleep are critical for pediatric development. Scientists link these specific sleep stages to essential milestones, including emotional regulation, physical growth, and neurodevelopment.
Study Methodology and Patient Demographics
To ensure a fair comparison, the researchers employed propensity score matching. They identified 342 melatonin users and paired them with 342 nonusers. The initial patient pool consisted of 346 melatonin users with a mean age of 9.5 years. The demographic breakdown of this group included 57.8% male patients and 42.2% female patients.
A notable disparity existed between the two groups regarding baseline health. Melatonin users presented with a higher comorbidity burden, averaging 10.0 unique ICD-10 chapters compared to 7.1 for nonusers. Conversely, the melatonin-using group showed lower rates of obstructive sleep apnea (68.5%) compared to the nonuser group (76.3%).
Clinical Considerations for Sleep Supplements
Because melatonin is available without a prescription, it is often viewed as a low-risk intervention for pediatric sleep issues.
Frequently Asked Questions
Does melatonin decrease total sleep time in children?
How does melatonin affect REM sleep?
The study found that children using melatonin had a lower median percentage of REM sleep (16.7%) compared to matched nonusers (19.0%).
Is this study considered high-quality evidence?
Yes. The study was assigned an Evidence Rating Level of 2, categorized as “Good,” due to its use of polysomnography, which is the gold standard for assessing sleep architecture.
Should parents stop using melatonin for their children?
This research provides observational data on sleep architecture but does not constitute medical advice. Parents should discuss specific sleep concerns and the use of supplements with their healthcare provider.
Have questions about pediatric sleep health or want to learn more about how research shapes clinical guidelines? Subscribe to our newsletter for the latest updates in medical research or join the conversation in the comments section below.